Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Oct 3, 2014

NEW YORK (GenomeWeb) – Bio-Rad Laboratories has appointed John Goetz as chief operating officer. Goetz has been with Bio-Rad for 40 years, serving in various capacities including division manager of quality systems and group operations manager. In 1999, he led the company's efforts to integrate the newly acquired Pasteur Sanofi Diagnostics business. In 2000, he was appointed to head the Clinical Diagnostics Group.

Bio-Rad also said that John Hertia has been appointed executive vice president and president of the Clinical Diagnostics group, succeeding Goetz. Hertia began his career with Bio-Rad 32 years ago and has held various positions including regional sales manager, marketing manager, and later division manager of the US sales division.

The Hercules, Calif.-based company also said that it has appointed Shannon Hall executive vice president and president of the Life Science group. Prior to this, Hall was vice president and general manager of the lab separations division in the Life Science group.

GenapSys has appointed Mark Pratt as vice president of product development. Most recently, Pratt was senior director of accuracy R&D at Personalis. Before that, he worked at Illumina, where he was responsible for engineering research, including holding leadership positions in the development of the HiSeq and MiSeq systems.

Agendia has named Jan Egberts its new CEO, replacing David Macdonald, who the firm said has left to pursue other opportunities. Egberts is an Agendia board member and most recently served as CEO of the specialty pharmaceutical company OctoPlus. He also has held business development and general management positions McKinsey & Co., Merck, Johnson & Johnson, and Mölnlycke Health Care, and was CEO of Novadel Pharmaceuticals.

Oligonucleotide developer and manufacturer Link has named David Ricketts as CEO. He will take over the position from current CEO John Bremner on Oct. 20. Ricketts was previously CEO of FibromEd, an Edinburgh University spinout commercializing stem cell products. Prior to this, he was CEO of Belgium's Pharma Diagnostics.

SQI Diagnostics has named Peter Winkley the chairman of its board of directors, replacing Claude Ricks. He is CFO of Algoma Central and has been a board member of SQI Diagnostics since 2007. Winkley also will continue to serve as chairman of SQI’s audit committee. Prior to joining Algoma Central, he was VP of finance and CFO of Therapure Biopharma.

ATCC has appointed Barbie Bigelow its executive VP of strategy and technology, and also has named Maryellen de Mars its senior director of the standards resource center.

Bigelow will lead integration of new products and services into ATCC’s portfolio and work with senior leadership on the execution of business plans. She previously worked for TASC and Lockheed Martin, where she served as chief information officer.

de Mars most recently served as COO and VP of clinical operations at United States Diagnostic Standards. She also previously worked for Gene Logic and Life Technologies. She will provide oversight for the ATCC Standards and Development Organization, which develops standards for biomaterials that meet ISO guidelines and are recognized by the American National Standards Institute.

Arrowhead Research has named Susan Boynton its VP of global regulatory affairs. In the role, she will direct the company's regulatory initiatives and strategy. She most recently served as vice president and head of North American regulatory affairs at Shire. Before that, she held various regulatory roles at Amgen, Abbott, Sanofi, and Novartis.

Biotec Pharmacon has hired Jethro Holter as managing director of its ArcticZymes subsidiary. Holter will join the company on Jan. 1, 2015, from the Norewegian operations of Thermo Fisher Scientific's Life Technologies, where he is responsible for OEM and licensing.

NeoGenomics has appointed Robert Shovlin as Chief Operating Officer, effective Oct. 13. He was Chief Development Officer for Bostwick Laboratories where he was responsible for sales, marketing, managed care, business development, and clinical trials. Before that, he held several positions at Aureon Biosciences, including president and CEO. Shovlin was also executive director for anatomic pathology and director of managed care for Quest Diagnostics.

Quest Diagnostics announced that Franklin Cockerill, III, is its new VP and chief laboratory officer as of Oct. 1. Cockerill was most recently CEO of Mayo Medical Laboratories and served as the chair of laboratory medicine and pathology for the Mayo Clinic. He has held several leadership positions, including chairing the Microbiology Devices Panel of the US Food and Drug Administration’s Medical Devices Advisory Committee; serving as an editor of the Journal of Clinical Microbiology; and serving as a program chair and board member of the Association for Molecular Pathology.

At Quest, Cockerill will oversee Quest’s lab network and lead the firm’s medical affairs strategies and academic and government collaborations. He will replace Stephen Suffin, who is retiring at the end of the year but will continue to consult through 2015.

Cypher Genomics said that it has appointed J. Patrick Ravenel to serve as its new chief technology officer. He previously served as VP of software development at MedImpact Healthcare Systems.

AuraSense Therapeutics has named Gordon Beck as its vice president of business development. The company has also added Helen Kim to its board of directors.

Beck previously served as executive director of global business development at Hoffmann-La Roche and currently sits on the New York University Venture Fund Biotech Review Board.

Kim is currently a special advisor to NGM Biopharmaceuticals. She previously served as CEO of Kosan Biosciences prior to its acquisition by Bristol-Myers Squibb.

Maverix Biomics has added Jim Bristow to its scientific advisory board.

Bristow is currently the deputy of science at the Department of Energy's Joint Genome Institute, where he is responsible for developing and implementing the Community Science Program, which provides sequencing and analysis for projects of relevance to DOE missions in energy and environment. He also oversees JGI's plant, fungal, microbial, and metagenome science programs. Previously, Bristow was a faculty member at University of California, San Francisco. He also has held leadership positions on several grant review boards and advisory committees for the American Heart Association, the National Institutes of Health, and DOE.

Core Informatics has hired Kevin Cronin as its chief commercial officer.

Cronin brings 25 years of experience leading sales and marketing teams serving pharmaceutical, agrochemical, consumer, and chemical companies. He joins Core from Dassault Systemes BIOVIA (formerly Accelrys), where he was most recently VP of its North American life science division and, prior to that, was Accelrys VP for global strategic accounts. He's also worked at Symyx and at NextBio — now owned by Illumina.

NantHealth has appointed several new members to its management team. Steve Curd, a former COO of WebMd, chief information officer of United Healthcare, and CEO of VantageMed, has joined the firm as COO. Laura Beggrow has joined the firm as executive VP of commercialization. She previously served as president of Strand Diagnostics, and prior to that she was VP of US sales and marketing at Genomic Health.

Other appointments included Stevie Davidson as senior VP of professional services; Michael Davis as senior VP of corporate strategy and business; Shannon Hastings as senior VP of product engineering; Mark Heinemeyer as senior VP of product management; Vasu Randagass as senior VP of strategy and research; Paul Fowler as senior VP of client services; Siew Yong Sim-Tang as VP of strategic planning; and Martin Walsh as VP and GM, UK.

Mayo Clinic added Catherine Ivy to its Arizona Leadership Council. Ivy is the founder and president of the Ben & Catherine Ivy Foundation, a brain cancer research foundation based in Phoenix. She will serve a three-year term on the council, which is an advisory and philanthropic group advocating for Mayo’s Clinic.

Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.